hero section gradient
15 handpicked stocks

America's Chip Moat: Navigating Export Controls

The recent arrest of two individuals for illegally exporting high-end Nvidia AI chips to China highlights the U.S. government's crackdown on technology transfers. This intensified enforcement of export controls could benefit U.S.-based semiconductor companies and those involved in securing the domestic supply chain.

Author avatar

Han Tan | Market Analyst

Published on August 6

Your Basket's Financial Footprint

Market capitalisation breakdown for the basket 'America's Chip Moat: Navigating Export Controls'.

Key Takeaways for Investors:
  • Large-cap dominance tends to reduce volatility and align performance with broad market trends, indicating lower relative risk.
  • Treat this basket as a core, long-term holding for portfolio stability rather than a short-term speculative position.
  • Expect steady, gradual appreciation over time; unlikely to deliver explosive, short-term gains.
Total Market Cap
  • INTC: $178.03B

  • TSM: $1.23T

  • ASML: $400.56B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Recent enforcement actions against illegal chip exports to China signal a major shift in U.S. technology policy. Stricter export controls could redirect demand and investment towards domestic semiconductor companies, creating opportunities for firms that form the backbone of America's chip ecosystem.

2

What You Need to Know

This group focuses on U.S.-based semiconductor companies including chip designers, manufacturers, and equipment suppliers. These firms are positioned to benefit from government initiatives aimed at strengthening domestic production capabilities and reducing reliance on foreign supply chains.

3

Why These Stocks

Each company was handpicked by professional analysts for their strategic role in the U.S. semiconductor supply chain. They represent key players positioned to benefit from the onshoring of chip production and increased government support for domestic technology leadership.

Why You'll Want to Watch These Stocks

🛡️

National Security Priority

These companies are at the heart of America's technology independence strategy. Government support and policy changes could drive significant growth opportunities.

🏭

Onshoring Momentum Building

The push to bring chip production back to America is creating massive investment opportunities. These firms are positioned to capture this historic shift in manufacturing.

Export Control Advantage

Stricter controls on technology exports could redirect billions in demand towards these domestic players. Recent enforcement actions show this trend is accelerating.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Beverage Stocks: What's Next After Coca-Cola's Pivot

Beverage Stocks: What's Next After Coca-Cola's Pivot

Coca-Cola is discontinuing its historic Minute Maid frozen products to focus on faster-growing beverage categories. This strategic shift highlights a broader investment opportunity in companies leading the market's transition toward healthier, more convenient, and functional drinks.

Factory Automation Stocks | Rising Labor Costs Trend

Factory Automation Stocks | Rising Labor Costs Trend

Volkswagen's recent agreement with the UAW signals a new era of rising labor costs for foreign automakers in the U.S. This theme focuses on companies poised to benefit as the industry increases investment in factory automation and robotics to enhance productivity.

Blood Thinner Breakthrough Explained | Market Overview

Blood Thinner Breakthrough Explained | Market Overview

Bayer's successful Phase III trial for its new blood thinner has demonstrated a significant reduction in stroke recurrence. This breakthrough positions the company favorably against competitors and highlights an investment opportunity in the evolving landscape of cardiovascular treatments.

Frequently Asked Questions